PTC Therapeutics Stock (NASDAQ: PTCT) stock price, news, charts, stock research, profile.
Open | $29.480 |
Close | - |
Volume / Avg. | 97.929K / 996.093K |
Day Range | 29.000 - 29.820 |
52 Wk Range | 17.530 - 59.840 |
Market Cap | $2.258B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 18.26% |
Days to Cover | 11.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PTC Therapeutics (NASDAQ: PTCT) through any online brokerage.
Other companies in PTC Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Syndax Pharmaceuticals (NASDAQ:SNDX) and Fusion Pharmaceuticals (NASDAQ:FUSN).
The latest price target for PTC Therapeutics (NASDAQ: PTCT) was reported by Jefferies on Wednesday, March 20, 2024. The analyst firm set a price target for 35.00 expecting PTCT to rise to within 12 months (a possible 18.52% upside). 50 analyst firms have reported ratings in the last year.
The stock price for PTC Therapeutics (NASDAQ: PTCT) is $29.53 last updated Today at March 28, 2024 at 11:39 AM EDT.
There are no upcoming dividends for PTC Therapeutics.
PTC Therapeutics’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for PTC Therapeutics.
PTC Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.